Surface Hippy® - Guide To Hip Resurfacing

Serving The Patient Community Since 12/11/2005     Patricia Walter Owner/Webmaster

Clusty

To Advertise
Contact Patricia
2000+ Unique Visitors a day

Hip Resurfacing News

 

FDA to Stryker: Fix hip implant flaws

FDA to Stryker: Fix hip implant flaws

Link to Original Article SNBC

 By LINDA A. JOHNSON updated 5:48 p.m. ET, Wed., Jan. 16, 2008

TRENTON, N.J. - Federal regulators have ordered medical device maker Stryker Corp. to fix a host of long-standing problems in its manufacturing of hip replacement parts that have triggered multiple patient complaints and forced some to have follow-up surgeries. Stryker shares fell almost 2 percent.

The U.S. Food and Drug Administration told Kalamazoo, Mich.-based Stryker in a letter that it was aware that the company has received patient complaints since January 2005 about a range of problems, including improper fitting of hip implants that caused bone fractures. Patients also have complained about pain, difficulty walking and "squeaky" joins, and some have had pieces of implant parts break off or wear down unevenly.

The six-page warning letter was prepared after FDA officials spent six weeks last summer inspecting the company's orthopedics division headquarters in Mahwah, N.J., which houses manufacturing operations, research and development and administrative offices.

The letter discusses deficiencies found during those inspections and repeatedly states that four company responses on those issues, sent between Aug. 1 and Nov. 2, were inadequate for a variety of reasons.

"Your firm has failed to perform corrective and preventive actions in order to prevent the recurrence of nonconforming product or other quality problems," the Nov. 28 letter states repeatedly.

FDA said in the letter that if Stryker does not correct the violations promptly, FDA can act without notice and seize property, levy fines and seek injunctions. The letter also notes that the FDA will not approve sale of certain new Stryker medical devices until the violations are fixed and that it will notify federal agencies about the warning letter, so they can consider it when awarding contracts.

A heavily redacted version of the letter was posted Tuesday on the agency's Web site.

FDA noted that some parts of the plant were found to be contaminated with disease-causing germs, including "clumps and clusters" of a form of Staphylococcus bacteria.

"Your firm has not identified the root causes of the microorganism contamination and has not executed corrective and preventive action to prevent recurrence," the letter states.

Stryker officials declined an interview request from The Associated Press Wednesday, but provided a prepared statement.

"We take these matters very seriously and are committed to developing, manufacturing and marketing medical products that are safe and effective and that comply with applicable laws and regulations," it said. "We have been working diligently for the past several months to respond to the FDA and will continue to work closely with them to address these matters."

Stryker was among five companies, which together provide nearly all replacement hips and knees in the U.S. market, that in September agreed to pay $310 million and accept federal monitors to settle allegations they gave doctors kickbacks to use their products.

Stryker shares fell $1.36, or 1.9 percent, to $69.75 in trading Wednesday.

 

Advertisement


View My Stats

Statistics Page

Web design by Patricia Walter Copyright Surface Hippy® 12/11/2005

Mission Statement - Surface Hippy® is a patient to patient guide to hip resurfacing. It does not provide medical advice. It is designed to support, not to replace, the relationship between patient and clinician.
Advertising - Revenue from this site is derived from commercial advertising and individual donations.
Any advertisement is distinguished by the word "advertisement"
Privacy - Surface Hippy® does not share email addresses or personal information with any group or organization.
Content - Surface Hippy® is not controlled or influenced by any medical companies, doctors or hospitals.
All content is controlled by Patricia Walter  -
Joint Health Sites  LLC
This site is published by Joint Health Sites LLC, which is solely responsible for its content.
The advertisements on this site are not intended by the advertisers as an endorsement of the site's content.
The advertisers shall not be liable for any errors or omissions in the site's content,
nor liable for any damages from any person's actions based in reliance on the site's content.